INCY

#611
Incyte Corporation - Common Stock
96.6 5 USD
-0.85%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
96.56
97.99
Year Range
63.92
112.29
Daily Change
-0.85%
Monthly Change
-3.67%
6 month change
-6.43%
Year Change
+47.09%
Previous Close
97.4 8
Open
97.7 5
Low
96.5 6
High
97.9 9
Volume
161
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 19.31 B
  • Employee 2 844
  • Founded 2002
  • CEO Hervé Hoppenot
  • Website www.incyte.com
  • Headquarter Delaware, United States
  • FIGI BBG000BNPSQ9
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
13.29
Price to sales ratio
3.54

Incyte Corporation - Common Stock

Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia. Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity.

News